Exact Sciences Balance Sheet Health
Financial Health criteria checks 4/6
Exact Sciences has a total shareholder equity of $3.2B and total debt of $2.6B, which brings its debt-to-equity ratio to 80%. Its total assets and total liabilities are $6.7B and $3.5B respectively.
Key information
80.0%
Debt to equity ratio
US$2.57b
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.02b |
| Equity | US$3.21b |
| Total liabilities | US$3.54b |
| Total assets | US$6.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: E2XA34's short term assets ($1.5B) exceed its short term liabilities ($723.7M).
Long Term Liabilities: E2XA34's short term assets ($1.5B) do not cover its long term liabilities ($2.8B).
Debt to Equity History and Analysis
Debt Level: E2XA34's net debt to equity ratio (48.2%) is considered high.
Reducing Debt: E2XA34's debt to equity ratio has reduced from 109.2% to 80% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable E2XA34 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: E2XA34 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 14.1% per year.